Cutaneous melanoma diagnosis may impact total life expectancy

Evaluating the loss of life expectancy among patients diagnosed with cutaneous melanoma may help establish a lifetime prognosis for patients, according to a study.
“Commonly reported measures (5-year disease-free survival/relative survival ratio, and overall survival) are useful for summarizing cancer prognosis,” Sofi Vikström, MD, of the department of oncology-pathology at the Karolinska Institute and the department of pathology and cancer diagnostics at Karolinska Solna University Hospital in Sweden, and colleagues wrote. “These do not capture the impact of a cancer

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart